SecProbe.io

CORRESP
1
filename1.htm

RanMarine
Technology B.V.

Galileïstraat
15, 3029AL

Rotterdam,
The Netherlands

    August
    [1], 2023

Securities
and Exchange Commission

Division
of Corporate Finance

100
F Street, N.E.

Washington,
D.C. 20549

Attn:
Dale Welcome and Andrew Blume

Re:
RanMarine Technology B.V.

Registration
Statement on Form F-1 Filed July 11, 2023

File
No. 333-273199

Dear
Erin Donahue and Evan Ewing:

RanMarine
Technology B.V. (the “Company” or “Ranmarine”) previously submitted a Registration Statement
on Form F-1 (the “Registration Statement”) with the Securities and Exchange Commission (the “Commission”)
on July 11, 2023. Amendment No.1 to the Registration Statement (“Amendment No. 1”) has been revised to reflect the
Company’s responses to the comment letter to the Registration Statement received on July 25, 2023 from the staff of the Commission
(the “Staff”).

For
ease of review, we have set forth below each of the numbered comments of your letter followed by the Company’s responses thereto.
Unless otherwise indicated, capitalized terms used herein have the meanings assigned to them in Amendment No. 1 and all references to
page numbers in such responses are to page numbers in Amendment No. 1.

Registration
Statement on Form F-1

Our
ASVs may be copied by third parties operating from countries in which there is limited protection..., page 29

    1.
    We
    note your disclosure that “[d]espite our efforts, third parties have in the past infringed, as noted above, and may in the
    future infringe, on our proprietary rights or that otherwise seek to mimic or leverage our intellectual property.” Please update
    this risk factor, if material, to discuss past IP infringements and how your business has been impacted.

Response:
In response to the Staff’s comment, the Company respectfully advises the Staff that it does not believe that these past IP infringements
have had, or will have, a material effect on the Company’s business, financial condition or results of operation.

Principal
Shareholders, page 74

    2.
    We
    note your disclosure that the table does not reflect any “ADSs that may be purchased subject to conversion rights or warrant
    rights pursuant to the bridge financing.” Please revise to include all securities that each shareholder has the right to acquire
    within 60 days. Refer to the definition of “beneficial owner” in General Instruction F of Form 20-F.

Response:
In response to the Staff’s comment, the Company respectfully advises the Staff that it has revised the Principal Shareholders table
to include ADSs that may be acquired within 60 days.

Exhibit
Index, page II-3

    3.
    Please
    file the consent of Samuel Howe as a director nominee.

Response:
In response to the Staff’s comment, the Company respectfully advises the Staff that it has filed the consents of all three director
nominees as exhibits in Amendment 1.

    4.
    Please
    revise the fee table to include the underwriter warrants, ADSs underlying the underwriter warrants and the Shareholder ADSs, as applicable.

Response:
In response to the Staff’s comment, the Company respectfully advises the Staff that it has revised the fee table to include the
underwriter warrants, ADSs underlying the underwriter warrants and the Shareholder ADSs.

Should
you have any questions regarding the foregoing, please do not hesitate to contact our counsel, Darrin Ocasio of Sichenzia Ross Ference
LLP, at (212) 930-9700.

    Sincerely,

    Richard
    Hardiman

    Chief
    Executive Officer